Literature DB >> 21471301

Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.

Pål Johansen1, Antonia Fettelschoss, Beat Amstutz, Petra Selchow, Ying Waeckerle-Men, Peter Keller, Vojo Deretic, Leonhard Held, Thomas M Kündig, Erik C Böttger, Peter Sander.   

Abstract

Pathogenic mycobacteria escape host innate immune responses by blocking phagosome-lysosome fusion. Avoiding lysosomal delivery may also be involved in the capacity of mycobacteria to evade major histocompatibility complex (MHC) class I- or II-dependent T-cell responses. In this study, we used a genetic mutant of Mycobacterium bovis BCG that is unable to escape lysosomal transfer and show that presentation of mycobacterial antigens is affected by the site of intracellular residence. Compared to infection with wild-type BCG, infection of murine bone marrow-derived dendritic cells with a mycobacterial mutant deficient in zinc metalloprotease 1 (Zmp1) resulted in increased presentation of MHC class II-restricted antigens, as assessed by activation of mycobacterial Ag85A-specific T-cell hybridomas. The zmp1 deletion mutant was more immunogenic in vivo, as measured by delayed-type hypersensitivity (DTH), antigen-specific lymphocyte proliferation, and the frequency of antigen-specific gamma interferon (IFN-γ)-producing lymphocytes of both CD4 and CD8 subsets. In conclusion, our results suggest that phagosome maturation and lysosomal delivery of BCG facilitate mycobacterial antigen presentation and enhance immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471301      PMCID: PMC3122614          DOI: 10.1128/CVI.00015-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

1.  Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.

Authors:  M A Horwitz; G Harth; B J Dillon; S Maslesa-Galic'
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  New vaccines for tuberculosis.

Authors:  Stefan H E Kaufmann; Gregory Hussey; Paul-Henri Lambert
Journal:  Lancet       Date:  2010-05-18       Impact factor: 79.321

Review 3.  For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection.

Authors:  Anca Dorhoi; Stephen T Reece; Stefan H E Kaufmann
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

4.  The 19-kD antigen and protective immunity in a murine model of tuberculosis.

Authors:  V V Yeremeev; I V Lyadova; B V Nikonenko; A S Apt; C Abou-Zeid; J Inwald; D B Young
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

5.  Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination.

Authors:  J Hess; L Grode; I Gentschev; J Fensterle; G Dietrich; W Goebel; S H Kaufmann
Journal:  Microbes Infect       Date:  2000-12       Impact factor: 2.700

6.  LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest.

Authors:  Silvana K Rampini; Petra Selchow; Christine Keller; Stefan Ehlers; Erik C Böttger; Peter Sander
Journal:  Microbiology       Date:  2008-10       Impact factor: 2.777

7.  Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.

Authors:  Ronggai Sun; Yasir A W Skeiky; Angelo Izzo; Veerabadran Dheenadhayalan; Zakaria Imam; Erica Penn; Katherine Stagliano; Scott Haddock; Stefanie Mueller; John Fulkerson; Charles Scanga; Ajay Grover; Steven C Derrick; Sheldon Morris; David M Hone; Marcus A Horwitz; Stefan H E Kaufmann; Jerald C Sadoff
Journal:  Vaccine       Date:  2009-06-02       Impact factor: 3.641

Review 8.  Future vaccination strategies against tuberculosis: thinking outside the box.

Authors:  Stefan H E Kaufmann
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

9.  The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells.

Authors:  Muralidhar K Katti; Guixiang Dai; Lisa Y Armitige; Carlos Rivera Marrero; Sundarsingh Daniel; Christopher R Singh; Devin R Lindsey; Subramanian Dhandayuthapani; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Cell Microbiol       Date:  2008-01-31       Impact factor: 3.715

10.  Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages.

Authors:  Jim Sun; Xuetao Wang; Alice Lau; Ting-Yu Angela Liao; Cecilia Bucci; Zakaria Hmama
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more
  24 in total

1.  The endothelin system has a significant role in the pathogenesis and progression of Mycobacterium tuberculosis infection.

Authors:  Andre F Correa; Alexandre M Bailão; Izabela M D Bastos; Ian M Orme; Célia M A Soares; Andre Kipnis; Jaime M Santana; Ana Paula Junqueira-Kipnis
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

2.  Murine Flt3 ligand-generated plasmacytoid and conventional dendritic cells display functional differentiation in activation, inflammation, and antigen presentation during BCG infection in vitro.

Authors:  Chuang Meng; Xiaoyan Wang; Zhengzhong Xu; Maozhi Hu; Jiaying Liu; Zhiming Pan; Xiang Chen; Xinan Jiao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-05       Impact factor: 2.416

3.  BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.

Authors:  Pearl Bakhru; Natalie Sirisaengtaksin; Emily Soudani; Seema Mukherjee; Arshad Khan; Chinnaswamy Jagannath
Journal:  Cell Immunol       Date:  2013-12-11       Impact factor: 4.868

4.  Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus.

Authors:  Michael Dal Molin; Myriam Gut; Anna Rominski; Klara Haldimann; Katja Becker; Peter Sander
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

5.  Mycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activation.

Authors:  Cynthia Portal-Celhay; JoAnn M Tufariello; Smita Srivastava; Aleena Zahra; Thais Klevorn; Patricia S Grace; Alka Mehra; Heidi S Park; Joel D Ernst; William R Jacobs; Jennifer A Philips
Journal:  Nat Microbiol       Date:  2016-12-05       Impact factor: 17.745

Review 6.  Current efforts and future prospects in the development of live mycobacteria as vaccines.

Authors:  Tony W Ng; Noemí A Saavedra-Ávila; Steven C Kennedy; Leandro J Carreño; Steven A Porcelli
Journal:  Expert Rev Vaccines       Date:  2015-09-14       Impact factor: 5.217

Review 7.  A review of the BCG vaccine and other approaches toward tuberculosis eradication.

Authors:  Thomas Cho; Christopher Khatchadourian; Huy Nguyen; Yash Dara; Shuna Jung; Vishwanath Venketaraman
Journal:  Hum Vaccin Immunother       Date:  2021-03-26       Impact factor: 3.452

Review 8.  Current and novel approaches to vaccine development against tuberculosis.

Authors:  Mark J Cayabyab; Lilia Macovei; Antonio Campos-Neto
Journal:  Front Cell Infect Microbiol       Date:  2012-12-06       Impact factor: 5.293

9.  A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence.

Authors:  Carolyn M Shoen; Michelle S DeStefano; Cynthia C Hager; Kyi-Toe Tham; Miriam Braunstein; Alexandria D Allen; Hiriam O Gates; Michael H Cynamon; Douglas S Kernodle
Journal:  Vaccines (Basel)       Date:  2013-01-11

10.  Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation.

Authors:  Ewoud Bernardus Compeer; Thijs Willem Hendrik Flinsenberg; Susanna Geertje van der Grein; Marianne Boes
Journal:  Front Immunol       Date:  2012-03-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.